Clinical Trial Update: ABSK021 Food Effect Study in Healthy Subjects [Phase 1]

View source ↗

Summary

ABSK021 food-effect study in healthy subjects (Phase 1) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• ABSK021

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: Neoplasms | Phase 1 | Status: COMPLETED